Ultragenyx Pharma (RARE) PT Lowered to $124 at Cowen, Following Earnings
Tweet Send to a Friend
Cowen analyst Yaron Werber lowered the price target on Ultragenyx Pharma (NASDAQ: RARE) to $124.00 (from $158.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
